Virbac has been granted a Limited Marketing Authorisation in the UK for its Gudair vaccine, indicated for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (MAP). 

MAP is the causal organism for Johne's Disease, a chronic infection of the intestinal system for which there is no cure.

According to Virbac, Johne's Disease enters most flocks following the introduction of infected stock, often breeding rams, bought at markets without checks on disease provenance. It is then spread by the faeces of often apparently healthy animals but which can contain huge numbers of MAP. The main clinical sign is a thin ewe resulting in poor productivity followed by inevitable death. It can be passed between sheep and cattle.

Ovine Johne's Disease (OJD) in sheep is widespread in Australia where annual death rates of up to 17% have been seen in infected flocks. Virbac says that trials conducted there have demonstrated that vaccination with Gudair can reduce the number of deaths due to OJD by 90% and reduce the numbers of OJD-causing organisms excreted in sheep faeces by 90%.

Ken Sibley MRCVS, Technical Advisor at Virbac says that the number of infected flocks in the UK is unknown and the disease often remains  undiagnosed: "Johne's Disease can be a significant cause of loss in infected sheep flocks because of reduced productivity and high culling rates. Vaccination provides the only possible assurance when sourcing sheep from potentially infected flocks and will help to reduce losses from the disease should a farmer inadvertently introduce sheep into an infected flock.

"Lambs identified as replacements should generally be vaccinated between 4 and 16 weeks of age, subcutaneously behind the ear. Sheep over 16 weeks of age can also be vaccinated as this will reduce shedding of organisms in infected animals while bought-in replacements can be vaccinated on arrival at the farm.  Sheep require only one vaccination for their lifetime.

"Following its success in Australia, we are delighted to be able to offer Gudair to veterinary surgeons in the UK."

For further information, contact your Virbac territory manager or call: 01359 243243

Ceva Animal Health has rebranded its nutraceutical supplements for cats and dogs under its Logic brand.

The new Logic range, which previously included the company's dental products, now includes Logic Diar-Stop (previously known as Diarsanyl Plus) for digestive health, Logic Flexivet, a joint supplement and Logic Senilife, a nutraceutical which Ceva says has been shown to manage the signs of brain ageing.

The range is available in consumer-friendly packaging and a merchandising unit is available to showcase the products in practice.

Claire Russell, consumer product manager at Ceva Animal Health said: "The new Logic range provides veterinary practices with an extensive portfolio of respected veterinary strength supplements and dental products, with more exciting and innovative products to come in the pipeline."

For further information on the Logic range, visit www.logicforpets.co.uk, contact your local Ceva Animal Health territory manager or call Ceva's customer support team on 01494 781510.

Elanco Companion Animal Health has launched a dermatology e-newsletter called Under The Skin, designed to help veterinary professionals stay informed and up to date on a wide range of skin conditions.

Featuring a guest editor for each edition, experts will review interesting case studies and research papers and discuss diagnosis and treatment options.

The launch issue focuses on otitis and is edited by Dr Peri Lau-Gillard DerMedVet CertVD DipECVD MRCVS, European Specialist in Veterinary Dermatology. 

Topics include a review of a clinical case - Pseudomonas otitis in a Cocker Spaniel called Rosie, a video otoscopy before and during Rosie's ear flush, information on antimicrobial resistance (AMR), a discussion on whether to carry out in-house ear cytology, product information on Surolan and a review of the causes of otitis.

The newsletter also features hints and tips on how to prevent contamination of ear medication/ear cleaners, the importance of marking products with expiry dates, information on applying topical ear cleaners/ear medication and owner education on how to apply the medication.

To receive priority notification of future editions of Elanco's 'Under The Skin' e-newsletter, register at www.thewebinarvet.com/elanco

For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.

IDEXX Laboratories has unveiled the Angio Detect Test, a world-first diagnostic test which allows veterinary surgeons to detect the lungworm Angiostrongylus vasorum in clinic, with almost immediate results.

Until now, vets have had to rely on the Baermann method to detect A. vasorum, which can present with varied and confusing clinical symptoms. However, the Baermann test has had limited use because it requires faecal samples from the same dog to be collected on three successive days, and the results can be compromised by the intermittent shedding of larvae. IDEXX says this leads many experts to believe that A. vasorum is widely under-diagnosed.

The Angio Detect Test works by detecting an A. vasorum specific antigen in the animal's blood. The test can be used in-clinic using a serum or plasma sample and returns results within 15 minutes. Depending on results, you can offer a licensed treatment or talk about a preventative treatment regime and refer the client to a source of further information, such as lungworm.co.uk.

IDEXX suggests that because the test is inexpensive, it can be used for the diagnosis of A. vasorum suspect dogs and in those with non-specific signs. Indeed, in market research¹, 94% of veterinary surgeons said they would use the test in dogs presenting with A. vasorum signs.

In endemic areas, it can be considered as an additional pre-surgical measure to avoid complications associated with coagulopathy. 

This test comes at a time when concern about A. vasorum has been growing. A survey of 150 veterinary practices across the UK in January 2013 recorded a total of 952 suspected cases (157 laboratory confirmed), with 81 deaths thought to have been caused by the parasite². The Angio Detect Test should help to improve the picture, as confirmed cases are logged onto incidence maps so vets can check prevalence in their area.

Ian Wright from the European Scientific Counsel Companion Animal Parasites (ESCCAP) said: "In recent years, there has been spread of the A. vasorum parasite across the UK with cases now being reported as far north as Scotland. It was initially thought this may be due to increased reporting rather than genuine spread, but this pattern in the UK has been mirrored in many other countries and would appear to represent a true emergence of disease. Although the cause of this spread is not known for certain, increasing slug and snail numbers combined with increased pet movement and urbanisation of foxes are all likely to have played a significant part. These factors make A. vasorum a year round rather than seasonal threat. 

"Any new diagnostic test that can quickly confirm a case of lungworm is a fantastic development and will help save dogs' lives and give us even greater insight into the extent of the spread of the parasite."

Graham Bilbrough, veterinary surgeon and European medical affairs manager for IDEXX Laboratories, said: "Up until now, testing methods have been time consuming to the client and costly, so the launch of the Angio Detect Test, together with recognition of clinical signs and early treatment will really help to prevent A. vasorum related fatalities in dogs. We also know that some dogs have subclinical angiostrongylosis, and this new test will help uncover this hidden problem before the surgical blade makes a cut. Difficulties in diagnosis have also meant that the full prevalence of A. vasorum in the UK has been relatively unknown. This test will allow veterinary surgeons to quickly identify the parasite and treat it if found. They shouldn't forget that other dogs in the household and the area are also at particular risk from the parasite."

The Angio Detect Test is available now in the UK, and will be launched in other European countries later this year. For more information on the test, visit www.idexx.co.uk/angio or speak to your IDEXX sales representative. For further information and free CPD on A. vasorum and other parasites, visit www.jungleforvets.co.uk or speak to your Bayer territory manager.

References

1. Focus group research and quantative market research comissioned by IDEXX Laboratories, Inc. April and March 2013.
2. Survey of 150 veterinary practices conducted by Opinion Matters, January 2013.

Merial Animal Health has launched Locatim, an oral antibody supplement to aid calf scour management.

Manufactured from the colostrum of high health status cows that are hyper-immunised against E.coli, rotavirus and coronavirus, Locatim contains a guaranteed concentration of specific antibodies to enterotoxic E.coli F5 (K99).

Merial says that when given alongside the dam’s colostrum, Locatim provides enhanced protection against infection, reducing calf mortality due to neonatal diarrhoea caused by E.coli F5 (K99), and helping to protect calf health during the critical rearing period.

According to the company, a single 60ml oral dose provides direct transfer of these specific antibodies, giving local protection within the digestive tract and systemic protection following absorption through the intestinal mucosa.

For optimal absorption Locatim should be administered during the first four hours of life, but it can be given up to 12 hours after birth.

Locatim can be administered to every calf born during an outbreak of scour; at times of peak calving, when environmental challenge is high; or it can be used to enhance protection in individual calves identified as being at high risk of disease due to factors such as dystocia, weakness or the poor quality of the dam’s colostrum.

For information on purchasing stock contact your local Merial Animal Health territory manager.  

The RCVS Council has announced its agreement with wholesale reform of the College’s governance arrangements to improve the efficiency and accountability of its decision-making processes.

The changes agreed by Council included almost halving the number of Council members and formalising lay and veterinary membership.

Under the proposals approved by Council it would be reduced to 24 members – comprising 13 elected veterinary surgeons (constituting a majority of Council), six appointed laypeople, three members appointed on behalf of the UK veterinary schools and two veterinary nurses. There would also be the option to appoint an additional member on behalf of any allied professions that RCVS Council may choose to regulate as associates of the College.

Professor Stuart Reid, Senior Vice-President of the RCVS and Chair of the Governance Panel that developed the recommendations, said:  "I am delighted that Council so fully supported our proposals for a new structure. The new composition will ensure that both veterinary nurses and laypeople have a guaranteed place at the Council table, as well as maintaining a majority of elected veterinary surgeons and important input from the veterinary schools.

"The proposal recognises the unique nature of the RCVS and will allow us to expedite our decision-making process, making us more fleet of foot and better able to respond to the needs of the profession and the public. It has also been constructed to allow Council to evolve its position, ensuring it remains relevant into the future. If all goes well we hope that the changes could come into force as soon as March 2017."

Liz Cox, the Chair of VN Council, particularly welcomed the changes in respect of veterinary nursing representation on RCVS Council, adding: "It is an historic decision for veterinary nurses and one that has been long awaited. It is only right that those who work so closely alongside veterinary surgeons in practice should have a direct input into regulation that affects us all."

Council’s approval of the recommendations was the culmination of two years of debate and consultation with the profession and other stakeholders. This included a formal consultation by the Department for Environment, Food and Rural Affairs (Defra) last year which garnered 52 responses – including from the British Veterinary Association - most of which were supportive. Different options for reform had, in turn, been developed by a Governance Panel, chaired by Professor Reid, which was set up by Council in March 2015 to consider various options.

Defra will now run a short informal consultation to provide those who responded to the initial consultation the opportunity to comment on the proposed reforms. If no issues are raised Defra officials will seek approval from the Government to proceed with a legislative reform order (LRO) to make the necessary changes to the Veterinary Surgeons Act.

This LRO will be scrutinised by parliamentary committee and voted on in both the House of Commons and House of Lords. Once this has been passed there will be a three-year transitional period, agreed by Council members, during which Council’s numbers would be gradually reduced.

Virbac has announced the launch of the Compulsory Chipping Support Pack, designed to help veterinary practices raise awareness of the importance of microchipping and the new legislation coming to England, Scotland and Wales in April.

The pack contains a range of promotional and educational items including: 

• A customisable poster to include practice logos and a promotional offering.
• A large BackHome display for the window, the doors - wherever it can best promote microchipping to the public.  
• Further material to help customise displays.
• Colour-coordinated bunting and balloons for creativity in decorating the practice.
• A range of 'wobblers' for shelves or reception desks to remind clients to chat to your reception and book their microchipping appointment.

Sarah Walker MRCVS, BackHome Product Manager, said: "Compulsory microchipping comes in this April and awareness needs to be raised among the general public – numerous reports in the media still show a significant proportion of dogs are not yet microchipped.  The new BackHome Mini Chip has a 34% smaller needle than our standard needles and is ‘one size fits all animals’, making it easier than stocking different chips for different size pets.

"The resources in our Compulsory Microchipping Support Pack are great for practices to use. We want to help practices and the teams working within them to engage with the public in their vicinity and help to drive practice footfall."

Greater collaboration between disciplines to promote the 'One Health' approach for people and pets could save the NHS 2.5 billion a year, according to Danny Mills, Professor of Veterinary Behavioural Medicine at the University of Lincoln.

Professor Mills, an authority on companion animal behaviour, cognition and welfare, made the claim at Purina’s 'Better with Pets' European Forum in Brussels, where experts in the animal and human relationship gathered recently to discuss the benefits that pets can have to public health.

Professor Mills highlighted how animal assisted activities and therapy (AAT), where animals are used to improve social, emotional and cognitive functioning, supporting recovery and rehabilitation, can play an important role in the cost saving. He also noted how pets have been shown to reduce anxiety in those with autism, while also easing the stress levels of parents and carers.

Attendees at the event heard  an example of AAT in practice at the Sant Joan de Déu-Barcelona hospital in Spain where a functional unit has been in operation for the past six years. Here, sick children receive AAT on the advice of a doctor, both in the emergency room and on an inpatient basis. The hospital reports that the dogs help the children to have a better life and cope more effectively with their illnesses. Purina called on the public health community to recognise the advantages of AAT and to play an active part in supporting this vital element of public health care.

The panel – which also included Andrea Meisser, Vice-President of the Institute for Interdisciplinary Research on the Human-Animal Relationship, Ruud Tombrock, Director for the Europe Region of World Animal Protection, and Andrea Gavinelli, Head of Unit at the European Commission’s Health and food safety Directorate General – noted that while the benefits of the bond between people and pets are widely felt, they are sometimes hard to quantify empirically.

Professor Mills noted that it can be challenging for researchers to have papers accepted by journals or funding bodies, making it difficult for policymakers to promote the benefits of pets for public health. The panel agreed that greater partnership between all disciplines – from researchers to veterinarians and policymakers – was crucial to advancing the understanding of the public health benefits of pets and people.

Discussing how policymakers could play a part in promoting the One Health approach, Mr Gavanelli called on the pet care community to work together to provide scientific examples and data highlighting economic and social benefits. He also noted that policymakers in Europe had an important part to play by taking a holistic approach to the issue.

Professor Mills said: "The benefits of responsible pet ownership are clear. I’ve seen pets have dramatic effects on autistic children. Understanding the subtleties and nuances of how people and pets work together is vitally important for the well-being of both, and has the potential to make a massive difference to public health. But it is crucial that the industry is given an opportunity to analyse this further. Ignoring the evidence is a far greater problem than dismissing the research as being at an early stage."

Public Health England has released figures showing that the number of people testing positive for Lyme disease was up over 30% in the period July to September 2015, from 300 lab confirmed cases to 421.

The figures are being highlighted by MSD Animal Health, organisers of the Bravecto 'Big Tick Project', a campaign to raise awareness of tick-borne disease amongst vets and pet owners.

The TV presenter and naturalist Chris Packham said: "The rise in the number of confirmed cases of Lyme disease in the UK reported by Public Health England suggests the need for greater awareness of this damaging illness. Vets have a huge part to play in educating pet owners.

"As well as highlighting the risks that ticks present to both human and companion animal health we need to be more alert to the signs and symptoms of tick-borne disease and the sensible steps we can all take to protect ourselves and our animals.”

Professor Richard Wall who has led Bristol University’s Big Tick Project team said: "Given the reported increase in cases of Lyme disease, the results of the Big Tick Project study will help us to understand these changes both in terms of the longer seasonal activity of ticks and their increasingly widespread geographic location and could have important implications for both human and animal health by quantifying the diversity and prevalence of the pathogens they may be carrying."

According to the NHS around 2,000 to 3,000 people in the UK are affected by Lyme Disease each year but charities campaigning for greater awareness of the disease suggest this could be as many as 15,000.

Growing concern over the rise in the tick-borne infection has prompted Government ministers to set up a network of regional experts to help diagnose and treat the problem.

Last autumn, Health Minister Lord Prior told a House of Lords debate: "Some patients suffer debilitating illness with symptoms that persist after treatment for several months or longer."

Lord Prior revealed that the Department of Health is to set up a network of experts around the country to support GPs and hospital staff, most of whom have never seen cases of the disease. The increase in the disease is being blamed on rising numbers of tick populations which are active for longer due to climate change, a rise in numbers of wild mammals such as deer that host them.

The clinical signs of Lyme disease in dogs include recurrent lameness due to inflammation of the joints. Sometimes the lameness lasts for only three to four days either in the same leg or in other legs and the joints may be swollen, warm, and painful. In some cases, kidney failure may occur and the dog may exhibit such signs as vomiting, diarrhoea, lack of appetite, weight loss, increased urination and thirst.

The BSAVA has launched a new guide to help practices navigate compulsory canine microchipping legislation which comes into force on 6th April.

The 18-page guide provides information on all aspects of microchipping, including the differing implications of the legislation across England, Scotland, Wales and Northern Ireland.

It explains exemption certificates that veterinary surgeons may be asked to sign, provides clarity on roles and responsibilities and more details on adverse event reporting, which will become a legal requirement under the new rules. 

It also contains advice on when it is required or advisable to scan a dog in order to read the microchip and links to the updated RCVS guidance on microchips, microchipping and animals without microchips.

The guide has been accepted by the VMD and is supported by the RCVS.

The new microchipping legislation is aimed at improving animal welfare, promoting responsible ownership and tackling the illegal puppy trade. It is also hoped compulsory microchipping will improve collection of data on inherited diseases and disease outbreaks.

BSAVA President Tricia Colville (pictured right) said: "The BSAVA supports the permanent identification and registration of all dogs and cats, and other companion animals as appropriate, since the ability to individually identify an animal and trace the owner has the potential to improve animal welfare.

"Responsible pet ownership is at the core of the new legislation so as a profession we need to be clear on our responsibilities and do all we can to inform pet owners. We acknowledge that it may take time for the profession to adapt to the changes but this guide brings clarity and will prove helpful to vet practices across the UK."

The BSAVA is inviting members to report any problems they encounter to the BSAVA's Scientific Policy Officer Sally Everitt - s.everitt@bsava.com. The Association plans a further consultation at the end of the year to discover how the legislation enforcement has been received.

The guide will be available to members from the BSAVA website: www.bsava.com

Virbac has launched of Bovigen Scour, an emulsion for injection into cattle which reduces the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E.coli F5 (K99). 

Bovigen Scour works by actively immunising pregnant cows and heifers and providing passive immunity to their calves via colostrum. According to the company, the vaccine also helps to reduce the shedding of virus by calves infected with bovine rotavirus and coronavirus.

Virbac says a key benefit of Bovigen Scour is the vaccination protocol which offers a large window for injection, making it easier for vaccination planning. The primary course is administered in two shots, with first dose between 12 and 5 weeks before calving and the booster 3 weeks later. The annual booster is then due between 12 and 3 weeks before calving is expected. The vaccine is presented in two sizes: 15ml (5 doses) and 90ml (30 doses). The dosage per cow is 3 ml and the withdrawal time is nil in milk.

Virbac Large Animal Product Manager Brigitte Goasduf MRCVS said: "Bovigen Scour offers farmers flexibility and ease of use. The flexibility it gives in terms of scheduling the primary course and booster is particularly important and is highly relevant for beef cattle farmers as it can be difficult to know exactly when a cow is likely to calve and it is vital not to miss the vaccination window.   

"Bovigen Scour is also convenient to give because of the small volume of emulsion and because the injection is given intramuscularly. Its launch extends our large animal vaccine range, which includes Gudair, for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (Map)."

The International Veterinary Epilepsy Task Force (IVETF), a group of 26 veterinary practitioner, neuropharmacology, neuropathology and neurology experts led by Holger Volk, Professor of Veterinary Neurology and Neurosurgery at the RVC, has issued new guidelines for treating and caring for dogs with epilepsy.

The guidelines have been adopted by the American College of Veterinary Internal Medicine (ACVIM) and published in the form of a ‘consensus statement’ in the Journal of Veterinary Internal Medicine (JVIM).

Professor Volk, who co-chaired the consensus statement process, said: "I was honoured to have been asked to co-chair such an important forum in American veterinary practice. This will be another landmark paper to help improve the care vets deliver for the patients with epilepsy, both in America and beyond.

"Epilepsy is one of the most common neurological diseases encountered by veterinary surgeons and practitioners around the world. The prevalence of the condition means there have been numerous research studies carried out over the years. But, despite such frequent research, there has been a lack of consistency when it comes to diagnosis and treatment.

"This lack of cohesion and collaboration made it difficult for owners and veterinary professionals to communicate effectively on the issue of pet epilepsy. This has led to the global veterinary community changing its approach and, in recent years, working more closely together."

Professor Volk says the aim of these latest guidelines is to provide joined up and collaborative thinking, teaching and learning on various different aspects of the condition that specifically affect America. These include the development of treatment strategies and any potential issues with chronic anti-epileptic drug treatment.

The ACVIM guidelines follow on from seven in-depth consensus statements produced by the IVETF and published open access in BMC Veterinary Research last year, outlining recommendations and classifications on all aspects of canine epilepsy. It was the first time this many veterinary neurology clinicians and neuroscientists formally agreed on the key aspects of the condition.

Professor Volk, who is also the Clinical Director of the RVC’s Small Animal Referral Hospital, added: "There is a real exciting buzz around canine and feline Epilepsy currently. Finally getting to global consensus from the international veterinary community will accelerate research and lead to improved patient care and quality of life for owners and patients alike."